SCHEMBL2701192

SCHEMBL2701192

CONCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4344051 0.74
SCHEMBL8427297 0.74
SCHEMBL23446782 0.72
SCHEMBL27378001 0.72
SCHEMBL7168792 0.72
Hydrochloric Acid SCHEMBL5184236 0.72
SCHEMBL16436873 0.71
SCHEMBL23829690 0.71
SCHEMBL333675 0.71
SCHEMBL7055838 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104322485-A Boar frozen semen diluted powder SHANDONG XINJI ANIMAL HUSBANDRY CO LTD 2015-02-04 CN claimed
CN-104322484-A Freezing and unfreezing method for boar semen SHANDONG XINJI ANIMAL HUSBANDRY CO LTD 2015-02-04 CN claimed
US-12415831-B2 HPLC free purification of peptides by the use of new capping and capture reagents ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2025-09-16 US disclosed
CN-120202010-A Ligand-oligonucleotide conjugates and linkers for use therewith 上海京新生物医药有限公司 2025-06-24 CN disclosed
US-20230302145-A1 SURFACTANT PROTEIN C MIMICS DISPLAYING PATHOGEN- OR ALLERGEN-BINDING MOIETIES Maxwell Biosciences, Inc. 2023-09-28 US disclosed
CN-116406280-A Surfactant protein C mimetics exhibiting pathogen or allergen binding moieties 安纳利斯·E·巴隆 2023-07-07 CN disclosed
EP-4149509-A1 SURFACTANT PROTEIN C MIMICS DISPLAYING PATHOGEN- OR ALLERGEN-BINDING MOIETIES Barron, Annelise E. (US) 2023-03-22 EP disclosed
EP-1981512-B1 MODIFIED MACROMOLECULE STARPHARMA PTY LTD (AU) 2022-11-02 EP disclosed
CN-114206911-A Methods of treating hyperlipidemia disorders with axon-targeting factor-1 compounds 加利福尼亚大学董事会 2022-03-18 CN disclosed
US-20220064212-A1 HPLC FREE PURIFICATION OF PEPTIDES BY THE USE OF NEW CAPPING AND CAPTURE REAGENTS ROCHE DIAGNOSTICS GMBH (DE) 2022-03-03 US disclosed
EP-3908590-A1 HPLC FREE PURIFICATION OF PEPTIDES BY THE USE OF NEW CAPPING AND CAPTURE REAGENTS F. Hoffmann-La Roche AG (CH) 2021-11-17 EP disclosed
EP-2076525-A2 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE Wisconsin Alumni Research Foundation (US) 2009-07-08 EP disclosed
US-20090075842-A1 NEOGLYCORANDOMIZATION AND DIGITOXIN ANALOGS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-03-19 US disclosed
US-20090075842-A1 NEOGLYCORANDOMIZATION AND DIGITOXIN ANALOGS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-03-19 US disclosed
WO-2008067039-A9 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE WISCONSIN ALUMNI RES FOUND (US) 2008-10-16 WO disclosed
US-20080171787-A1 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-07-17 US disclosed
WO-2008067039-A2 COLCHICINE NEOGLYCOSIDES AND METHODS FOR THEIR SYNTHESIS AND USE WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2008-06-05 WO disclosed
US-7176230-B2 Synthesis of indole analogs of 1-benzyl-3-(5′-hydroxymethyl-2′-furyl) indazole (YC-1) as anti-platelet agents INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2007-02-13 US disclosed
CN-1751037-A Sulfonamide derivatives as PPAR modulators LILLY CO ELI (US) 2006-03-22 CN disclosed
US-6774212-B2 FOR THERAPY OF VIRAL INFECTION OR AS AN ASSAY STANDARD OR REAGENT BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-08-10 US disclosed